Glycemic control of type 2 diabetic patients after short-term zinc supplementation

  • Oh, Hyun-Mee (Department of Food and Nutrition, Keimyung University) ;
  • Yoon, Jin-Sook (Department of Food and Nutrition, Keimyung University)
  • Published : 2008.12.31

Abstract

This study was carried out to determine whether a short-tenn zinc supplementation contributes to beneficial changes in glycemic control among type 2 diabetic patients. Seventy-six diabetic subjects and 72 normal adults participated in this study. Subjects were divided into supplemented and control groups. Forty-four diabetic patients and 34 normal subjects were supplemented with 50 mg zinc daily as zinc gluconate for 4 weeks. Zinc status was assessed from fasting plasma levels and urinary excretion. The effects of zinc supplementation on fasting blood glucose, $HbA_{1c}$, insulin, and C-peptide were measured at the beginning of the study and after 4 weeks of supplementation. The changes in glycemic control indicators were compared between diabetic groups, classified by baseline $HbA_{1c}$ levels, and by diabetic duration. At baseline, the incidence of marginal zinc deficiency in the diabetic group, as determined by plasma zinc level, was approximately twice as high as in the normal adult group. The changes of $HbA_{1c}$ concentration, and fasting blood glucose following supplementation were not statistically significant in diabetic subjects. In normal subjects, a significant decrease of $HbA_{1c}$ occurred only in the zinc supplemented group. No significant changes were observed for serum insulin and C-peptide in diabetic as well as normal subjects. However, when the changes were compared by baseline $HbA_{1c}$ level, we found that diabetic subjects with $HbA_{1c}\;{\geq}\;7.5%$ showed significantly improved levels of $HbA_{1c}$ and fasting glucose after Zn supplementation. While such improvement in fasting blood glucose was significant among diabetics with shorter diabetic duration, significant levels of increase in serum insulin and C-peptide were observed in zinc supplemented subjects with longer diabetic duration. Fasting blood glucose was significantly decreased, whereas serum insulin and C-peptide were increased in diabetics with marginal zinc status. Therefore, we suggest that Zn supplementation for a short-term period may improve glycemic control in diabetic patients with higher $HbA_{1c}$ levels and marginal zinc status.

Keywords

References

  1. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM & Kerkeni A (2001). Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 20:212-218 https://doi.org/10.1080/07315724.2001.10719034
  2. Al-Maroof RA & Al-Sharbatti SS (2006). Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J 27:344-350
  3. Bonham M, O'Connor JM, Alexander HD, Coulter J, Walsh PM, McAnena LB, Downes CS, Hannigan BM & Strain JJ (2003). Zinc supplementation has no effect on circulating levels of peripheral blood leucocytes and lymphocyte subsets in healthy adult men. Br J Nutr 89:695-703 https://doi.org/10.1079/BJN2003826
  4. Chandra RK (1984). Excessive intake of zinc impairs immune responses. J Am Med Assoc 252:1443-1446 https://doi.org/10.1001/jama.252.11.1443
  5. Chausmer AB (1998). Zinc, Insulin and Diabetes. J Am Coll Nutr 17:109-115 https://doi.org/10.1080/07315724.1998.10718735
  6. Chen MD, Liou SJ, Lin PY, Yang VC, Alexander PS & Lin WH (1998). Effect of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol Trace Elem Res 61:303-311 https://doi.org/10.1007/BF02789090
  7. Cunningham JJ, Fu A, Mearkle PL & Brown RG (1994). Hyperzincuria in individuals with insulin-dependent diabetes mellitus : concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism 43:1558-1562 https://doi.org/10.1016/0026-0495(94)90016-7
  8. de Sena KC, Arrais RF, das Graças Almeida M, de Araujo DM, dos Santos MM, de Lima VT & de Fatima Campos Pedrosa L (2005). Effects of zinc supplementation in patients with type 1 diabetes. Biol Trace Elem Res 105:1-9 https://doi.org/10.1385/BTER:105:1-3:001
  9. Faure P, Benhamou PY, Perard A, Halimi S & Roussel AM (1995). Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 49:282-288
  10. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, Holzmeister LA, Hoogwerf B, Mayer-Davis E, Mooradian AD, Purnell JQ & Wheeler M (2003). Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications Diabetes Care. 26:S51-61 https://doi.org/10.2337/diacare.26.2007.S51
  11. Golik A, Cohen N, Ramot Y, Maor J, Moses R, Weissgarten J, Leonov Y & Modai D (1993). Type II diabetes mellitus, congestive heart failure, and zinc metabolism. Biol Trace Elem Res 39:171-175 https://doi.org/10.1007/BF02783187
  12. Heise CC, King JC, Costa FM & Kitzmiller JL (1988). Hyperzincuria in IDDM women : Relationship to measure of glycemic control, renal function, and tissue catabolism. Diabetes care 11:780-786 https://doi.org/10.2337/diacare.11.10.780
  13. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N & Kandhro GA (2008). Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 122:1-18 https://doi.org/10.1007/s12011-007-8062-y
  14. Keen CL & Gershwin ME (1990). Zinc deficiency and immune function. Annu Rev Nutr 10:415-431 https://doi.org/10.1146/annurev.nu.10.070190.002215
  15. Kim YI, Choi CS, Kim SW, Lee JS, Kim HH, Lee MS, Lee SI, Park JY, Hong SK & Lee KU (1998). Prevalence of Diabetes Mellitus and impaired glucose tolerance in Korean adults living in Jungup District, South Korea. J Kor Diabetic Associ 22:363-371
  16. Kinlaw WB, Levine AS, Morley JE, Silivis SE & McClain CJ (1983). Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273-277 https://doi.org/10.1016/0002-9343(83)91205-6
  17. King JC & Keen CL (1994). Zinc. In: Shils ME, Olson JA, Shike M(Eds), Modern nutrition in health and disease. 8th ed. p.214-230 Lea & Febiger, Malvern. UK
  18. Lee JH, Lee HJ, Lee IK & Yoon JS (2005). Zinc and copper status of middle- and old-aged woman in type 2 diabetes. The Korean Journal of Nutrition 38:56-66
  19. Levine AS, McClain CJ, Handwerger BS, Brown DM & Morley JE (1983). Tissue zinc status of genetically diabetic and streptozotocininduced diabetic mice. Am J Clin Nutr 37:382-386 https://doi.org/10.1093/ajcn/37.3.382
  20. Marchesini G, Bugianesi E, Ronchi M, Flamia R, Thomaseth K & Pacini G (1998). Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 47:792-798 https://doi.org/10.1016/S0026-0495(98)90114-7
  21. Ministry of Health & Welfare (2006). Report on 2005 National health and nutritional survey. Seoul, Korea
  22. Niewoehner CB, Allen JI, Boosalis M, Levine AS & Morley JE (1986). Role of zinc supplementation in type II diabetes mellitus. Am J Med 81:63-68
  23. Palumbo PJ (2001). Glycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus. Mayo Clin Proc 76:608-618
  24. Rink L & Kirchner H (2000). Zinc-altered immune function and cytokine production. J Nutr 130:1407s-1411s
  25. Rho SN & Ko HS (1997). A clinical properties on nutrients intake and serum concentration of diabetic subjects by duration in Ansung Kyunggi-do. The Korean Journal of Nutrition 30:1203-1210
  26. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM & Anderson RA (2003). Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr. 22:316-321 https://doi.org/10.1080/07315724.2003.10719310
  27. Roth H & Kirchgessner M (1981). Zinc and insulin metabolism. Biol Trace Elem Res 3:13-32 https://doi.org/10.1007/BF02789121
  28. Salgueiro MJ, Krebs N, Zubillaga MB, Weill R, Postaire E, Lysionek AE, Caro RA, Paoli TD, Hager A & Boccio J (2001). Zinc and Diabetes Mellitus. Is there a need of zinc supplementation in diabetes mellitus patients? Biol Trace Elem Res 81:215-228 https://doi.org/10.1385/BTER:81:3:215
  29. Simon SF & Taylor CG (2001). Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp Biol Med 226:43-51 https://doi.org/10.1177/153537020122600107
  30. Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW & Keen CL (1991). Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 14:1050-1056 https://doi.org/10.2337/diacare.14.11.1050
  31. Yoon JS (2008). Zinc status and dietary quality of type 2 diabetic patients: implication of physical activity levels. Nutrition Research and Practice 2:41-45 https://doi.org/10.4162/nrp.2008.2.1.41
  32. Yoon JS & Lee JH (2007). A suggestion to improve zinc status of type 2 diabetic women: relation among zinc, protein and phytate intake. Journal of Korean Dietetic Association 13:301-310